On the heels of sponsoring the 10th annual Summit for Clinical Ops Executives (SCOPE) last month, Praxis sent Tricia Barrett, SVP and managing director, and Bob Loll, SVP of business development and strategic planning, to London to attend the 11th Annual Patient Recruitment and Retention Summit. Praxis served as a Silver Sponsor at the summit, with Bob leading the way as chairperson for the second straight year.
Two major themes that emerged from the conference were:
- Patient voice. A hot topic of discussion was patient voice. Patients can – and want to – help improve the patient journey in a trial which, in turn, can lead to optimized trial results. As the patient voice continues to get louder in the drug development process, industry leaders are starting to listen.
- Rare disease. February 28 was Rare Disease Day, so it’s no surprise that this topic was front and center during this conference. According to the Genetic and Rare Diseases Information Center, a rare disease is defined as a condition that affects fewer than 200,000 people in the US. In the European Union, a disease is defined as rare when it affects fewer than 1 in 2,000 people. The summit provided a platform for industry experts to discuss and address the many challenges involved with both patient recruitment and retention for rare disease trials.
Each year, Praxis looks forward to this conference, as we continue to learn about the forever evolving approach our clients take to planning and management of clinical trials around the world.
Are you looking to take your campaign strategy global? Get in touch.
Until next time, cheerio!